IL309428A - Methods of using aldosterone synthase inhibitors - Google Patents
Methods of using aldosterone synthase inhibitorsInfo
- Publication number
- IL309428A IL309428A IL309428A IL30942823A IL309428A IL 309428 A IL309428 A IL 309428A IL 309428 A IL309428 A IL 309428A IL 30942823 A IL30942823 A IL 30942823A IL 309428 A IL309428 A IL 309428A
- Authority
- IL
- Israel
- Prior art keywords
- methods
- synthesis inhibitors
- aldosterone synthesis
- aldosterone
- inhibitors
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/38—Drugs for disorders of the endocrine system of the suprarenal hormones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/472—Non-condensed isoquinolines, e.g. papaverine
- A61K31/4725—Non-condensed isoquinolines, e.g. papaverine containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
Landscapes
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Epidemiology (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Diabetes (AREA)
- Endocrinology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202163214521P | 2021-06-24 | 2021-06-24 | |
| US202163290364P | 2021-12-16 | 2021-12-16 | |
| PCT/US2022/073148 WO2022272300A1 (en) | 2021-06-24 | 2022-06-24 | Methods of using aldosterone synthase inhibitors |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IL309428A true IL309428A (en) | 2024-02-01 |
Family
ID=84545863
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL309428A IL309428A (en) | 2021-06-24 | 2022-06-24 | Methods of using aldosterone synthase inhibitors |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US20240277698A1 (https=) |
| EP (1) | EP4358959A4 (https=) |
| JP (1) | JP2024523559A (https=) |
| KR (1) | KR20240035483A (https=) |
| AU (2) | AU2022299103B2 (https=) |
| BR (1) | BR112023027025A2 (https=) |
| CA (1) | CA3223211A1 (https=) |
| IL (1) | IL309428A (https=) |
| MX (1) | MX2023015121A (https=) |
| WO (1) | WO2022272300A1 (https=) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2024310688A1 (en) * | 2023-06-29 | 2026-01-29 | AstraZeneca Ireland Limited | Crystal form of baxdrostat, and preparation method therefor and use thereof |
| CN121712504A (zh) * | 2023-07-27 | 2026-03-20 | 矿物疗法公司 | 用洛伦司他及两种或更多种降压药的组合治疗高血压的方法 |
| TW202525278A (zh) * | 2023-12-15 | 2025-07-01 | 愛爾蘭商阿斯特捷利康愛爾蘭有限公司 | 治療慢性腎病及高血壓之方法 |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU4777896A (en) * | 1995-02-10 | 1996-08-27 | G.D. Searle & Co. | Use of low dose amount of spironolactone for treatment of cardiovascular disease |
| US20070196510A1 (en) * | 2006-02-17 | 2007-08-23 | Gerber Michael J | Method for treating resistant hypertension |
| US9353081B2 (en) * | 2011-09-23 | 2016-05-31 | Hoffmann-La Roche Inc. | Bicyclic dihydroquinoline-2-one derivatives |
-
2022
- 2022-06-24 WO PCT/US2022/073148 patent/WO2022272300A1/en not_active Ceased
- 2022-06-24 MX MX2023015121A patent/MX2023015121A/es unknown
- 2022-06-24 BR BR112023027025A patent/BR112023027025A2/pt unknown
- 2022-06-24 JP JP2023579554A patent/JP2024523559A/ja active Pending
- 2022-06-24 CA CA3223211A patent/CA3223211A1/en active Pending
- 2022-06-24 AU AU2022299103A patent/AU2022299103B2/en active Active
- 2022-06-24 US US18/569,853 patent/US20240277698A1/en active Pending
- 2022-06-24 IL IL309428A patent/IL309428A/en unknown
- 2022-06-24 EP EP22829524.2A patent/EP4358959A4/en active Pending
- 2022-06-24 KR KR1020247002601A patent/KR20240035483A/ko active Pending
-
2026
- 2026-03-16 AU AU2026201954A patent/AU2026201954A1/en active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| EP4358959A1 (en) | 2024-05-01 |
| WO2022272300A1 (en) | 2022-12-29 |
| AU2022299103A1 (en) | 2024-01-25 |
| KR20240035483A (ko) | 2024-03-15 |
| AU2022299103B2 (en) | 2025-12-18 |
| US20240277698A1 (en) | 2024-08-22 |
| AU2026201954A1 (en) | 2026-04-02 |
| JP2024523559A (ja) | 2024-06-28 |
| EP4358959A4 (en) | 2025-05-14 |
| CA3223211A1 (en) | 2022-12-29 |
| MX2023015121A (es) | 2024-04-16 |
| BR112023027025A2 (pt) | 2024-03-12 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL292754A (en) | Method of synthesis | |
| IL287787A (en) | Phenylaminopyrimidine amide autophagy inhibitors and methods of use thereof | |
| IL287795A (en) | Heteroarylaminopyrimidine amide autophagy inhibitors and methods of use thereof | |
| IL309428A (en) | Methods of using aldosterone synthase inhibitors | |
| IL286352A (en) | Novel small molecule inhibitors of tead transcription factors | |
| AR120184A1 (es) | Aminas bicíclicas como inhibidoras de la cdk2 | |
| EP4110333A4 (en) | Sos1 inhibitors | |
| IL288996A (en) | Aminopyrimidine amide autophagy inhibitors and methods of use thereof | |
| IL287751A (en) | Kcnt1 inhibitors and methods of use | |
| IL287768A (en) | Kcnt1 inhibitors and methods of use | |
| JOP20200081B1 (ar) | أملاح من مشتقات بيرولوتريازين مفيدة بوصفها مثبطات لـ tam | |
| EP4358963A4 (en) | SOS1 INHIBITORS | |
| PL3752251T4 (pl) | Inhibitory arginazy i sposoby ich stosowania | |
| EP4333821A4 (en) | SARS-COV-2 INHIBITORS | |
| IL314221A (en) | Synthesis of a kif18a inhibitor | |
| EP3901156A4 (en) | NITROOXY DERIVATIVE OF ROCK KINASE INHIBITOR | |
| EP4225310A4 (en) | HETEROARYL AMIDE INHIBITORS OF CD38 | |
| IL309571A (en) | Cdk2 inhibitors and methods of using the same | |
| EP4247372A4 (en) | PLASMA KALLICREIN INHIBITORS | |
| EP4396159A4 (en) | NIROGACESTAT SYNTHESIS | |
| EP4226919A4 (en) | FERROPTOSIS INHIBITOR | |
| EP4210694A4 (en) | PLASMA KALLICREIN INHIBITORS | |
| EP4384164A4 (en) | HYPOXIA-INDUCIBLE FACTOR INHIBITORS | |
| EP4405334C0 (en) | Sortilin inhibitors | |
| DK4192813T3 (da) | Inhibitorer af transglutaminaser |